(Q37536433)

20 August 2017

1 reference

title

WHO Guide for standardisation of economic evaluations of immunization programmes (English)

1 reference

World Health Organization

20 August 2017

main subject

0 references

0 references

1 reference

Damian G Walker

1

1 reference

20 August 2017

Raymond Hutubessy

series ordinal

2

1 reference

20 August 2017

Philippe Beutels

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

28 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

28

1 reference

20 August 2017

issue

11

1 reference

20 August 2017

page(s)

2356-2359

1 reference

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Economic evaluations of adult pneumococcal vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Is vaccination against hepatitis B efficient? A review of world literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Cost-effectiveness analyses of human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Cost-effectiveness of rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Funding of drugs: do vaccines warrant a different approach?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Development and validation of a grading system for the quality of cost-effectiveness studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Future costs in cost effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Modeling for health care and other policy decisions: uses, roles, and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Methodological issues and new developments in the economic evaluation of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

Public spending on health care: how are different criteria related?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

The GAVI Alliance's new vaccine strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.035

10.1016/J.VACCINE.2009.06.035

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference